Treatment options for metastatic renal cell carcinoma (RCC) are limited. In this study, we investigated impact of prostaglandin E2 (PGE2) receptor 4 (EP4) on RCC metastasis. We found that knockdown of EP4 in two RCC cell lines, ACHN and SN12C, does not affect xenograft tumor take or growth rate in mice, but reduces metastasis by decreasing tumor intravasation. Using chick chorioallantoic membrane (CAM) assay, we confirmed that blockade of EP4 signaling inhibits tumor intravasation. In vitro studies associated EP4 expression and activity with RCC cell transendothelial migration (TEM).
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2iw7zk3
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Recent updating of the World Health Organization (WHO) classification of central nervous system (CNS) tumors in 2016 demonstrates...
-
In our previous work, the dichloromethane-methanol (1:1 v/v) extract, fractions and isolated compounds from Polyscias fulva stem bark showed...
-
Background Agricultural work can expose workers to increased risk of heat strain and volume depletion due to repeated exposures to high ambi...
-
Cincinnati.com No fooling; go get your head (and neck) examined for free Cincinnati.com Thursday, get your head examined. UC Health ...
-
Nursing students' perceptions of a video-based serious game's educational value: A pilot study. Nurse Educ Today. 2017 Dec 28;...
-
Anaphora is a rhetorical term for the repetition of a word or phrase at the beginning of successive clauses or verses. from #AlexandrosSfa...
-
Abstract We introduce a novel diagnostic Visual Voiding Device (VVD), which has the ability to visually document urinary voiding events an...
-
Method combines radiomics with three - compartment breast image analysis of dual - energy mammography (Source: The Doctors Lounge - Oncology...
-
Cone beam computerized tomography (CBCT) has been widely used in dental implanting. However, the local hospitals usually don’t have access t...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου